Target selection in drug discovery
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Target selection in drug discovery--defined here as the decision to focus on finding an agent with a particular biological action that is anticipated to have therapeutic utility--is influenced by a complex balance of scientific, medical and strategic considerations. In this article, we provide an introduction to the key issues in target selection and discuss the rationale for decision making.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists are queued
They are fetched later and appear here then.
References 13 · Cited by 216
Research works printed but not linked: 2
- Jack, D. in Creating the Right Environment for Drug Discovery (ed. Walker, S. R.) 67–71 (Quay Publishing, Lancaster, 1991).
- Jones, R. H. An approach to pricing of innovative research-based medicine. Pharm. Med. 8, 29–38 (1994). An excellent overview that describes the approach used by research-based companies in identifying the right price for a new product.
Metadata
- Authors
- Knowles, J., & Gromo, G.
- Affiliations
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Knowles, Jonathan
- Gromo, Gianni
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-01
- Volume
- 2
- Issue
- 1
- Pages
- 63-69
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2803560454
- Cited by
- 216
- References
- 13
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 5 · 2018: 10 · 2017: 4 · 2016: 7 · 2015: 11 · 2014: 11 · 2013: 11 · 2012: 12
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- target selection, drug discovery, drug target identification, decision-making, drug development strategy
- MeSH terms
- Biotechnology, Drug Industry, Humans, Legislation, Drug, Pharmacology, Receptors, Drug, Health Care Sector
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Target selection in drug discovery. https://app.cochat.ai/papers/10.1038/nrd986
- The paper
- Knowles, J., & Gromo, G. (2003). Target selection in drug discovery. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd986
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.